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Mesenchymal Stem Cell Migration and Proliferation
Are Mediated by Hypoxia-Inducible Factor-1a
Upstream of Notch and SUMO Pathways
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Rubén Carrero,1 José Luis De La Pompa,3 José Anastasio Montero,1,2 and Pilar Sepúlveda1,2
Mesenchymal stem cells (MSCs) are effective in treating several pathologies. We and others have demonstrated that
hypoxia or hypoxia-inducible factor 1 alpha (HIF-1a) stabilization improves several MSC functions, including cell
adhesion, migration, and proliferation, thereby increasing their therapeutic potential. To further explore the mechanisms
induced by HIF-1a in MSCs, we studied its relationship with Notch signaling and observed that overexpression of HIF-
1a in MSCs increased protein levels of the Notch ligands Jagged 1–2 and Delta-like (Dll)1, Dll3, and Dll4 and potentiated
Notch signaling only when this pathway was activated. Crosstalk between HIF and Notch resulted in Notch-dependent
migration and spreading of MSCs, which was abolished by g-secretase inhibition. However, the HIF-1-induced increase
in MSC proliferation was independent of Notch signaling. The ubiquitin family member, small ubiquitin-like modifier
(SUMO), has important functions in many cellular processes and increased SUMO1 protein levels have been reported in
hypoxia. To investigate the potential involvement of SUMOylation in HIF/Notch crosstalk, we measured general
SUMOylation levels and observed increased SUMOylation in HIF-1-expressing MSCs. Moreover, proliferation and
migration of MSCs were reduced in the presence of a SUMOylation inhibitor, and this effect was particularly robust in
HIF-MSCs. Immunoprecipitation studies demonstrated SUMOylation of the intracellular domain of Notch1 (N1ICD) in
HIF-1-expressing MSCs, which contributed to Notch pathway activation and resulted in increased levels of N1ICD
nuclear translocation as assessed by subcellular fractionation. SUMOylation of N1ICD was also observed in HEK293T
cells with stabilized HIF-1a expression, suggesting that this is a common mechanism in eukaryotic cells. In summary, we
describe, for the first time, SUMOylation of N1ICD, which is potentiated by HIF signaling. These phenomena could be
relevant for the therapeutic effects of MSCs in hypoxia or under conditions of HIF stabilization.
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Introduction
Human mesenchymal stem cells (MSCs) from differentsources have attracted great interest in several areas of
medicine and biomedical research, particularly in the fields of
regenerative medicine and cell therapy. Indeed, we previ-
ously demonstrated the capacity of MSCs isolated from
dental pulp or bone marrow to treat myocardial infarction
[1,2] and other studies have shown the potential of MSCs to
treat ischemic diseases in preclinical and clinical models [3].
Sustained growth and maintenance of MSCs are key factors
for their therapeutic use as they ultimately undergo replica-
tive senescence after extended periods of normal growth
[4,5]. To overcome this limitation, we and others have pro-
posed culturing MSCs at reduced oxygen tensions or under
conditions of hypoxia-inducible factor (HIF) overexpression/
stabilization since these variables help to maintain cells in an
undifferentiated state [6,7]. HIF-1a is a pivotal transcription
factor regulating the adaptive response to hypoxia [8], and
numerous proteins interact directly with HIF-1 to enhance or
reduce its function [9–11]. Among them, HIF-1a interacts
with the highly conserved Notch signaling pathway [12,13],
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and the processes of migration, proliferation, differentiation,
and angiogenesis in precursor and tumor cells have all been
directly correlated with HIF-1a upstream of Notch signal-
ing [12,14–16]. The molecular mechanisms that regulate
Notch activity are, however, complex. Four Notch receptors
(Notch1–4) are found in mammals, which are activated by
five different ligands: Delta-like 1, 3, and 4 (Dll1, Dll3, and
Dll4) and Jagged 1 and 2 [17–19]. Among these, Notch1 and
Jagged1 are the most widely studied [20]. Ligand binding to
the Notch1 receptor causes a conformational change in its
intracellular domain that allows its cleavage by g-secretase,
resulting in the release of the Notch intracellular domain
(NICD) [21]. NICD subsequently translocates to the nucleus
where it activates the transcription of Notch target genes,
including Hes1, Hey1, and Hey2 [17,22].
Recently, an interaction between the Notch1 receptor and
the SUMOylation cascade has been described in breast cancer
[23]. Small ubiquitin-like modifier (SUMO), a small (11 kDa)
ubiquitin-like protein, can covalently attach to proteins as a
post-translational modification and influence their stability,
localization, or activity [24]. Notch1 signaling can deplete
the unconjugated SUMO1 pool, which selectively impairs the
growth of Notch1-activated cells. However, whether cross-
talk between HIF-1, Notch1, and SUMO signaling path-
ways is involved in the control of MSC behavior is unknown.
The aim of the present study was to examine the regulation
of proliferation, migration, and spreading in MSCs through
crosstalk between HIF-1a, Notch, and SUMO signaling
pathways.
Materials and Methods
All experiments were carried out in accordance with the
approved guidelines and approved by the Instituto de Salud
Carlos III and institutional ethics and animal care committees.
Cell lines and lentiviral labeling
Human MSCs obtained from dental pulp were purchased
from Inbiomed (Inbiobank, San Sebastian, Guipuzcoa, Spain).
Cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM)-low glucose (Gibco, Grand Island, NY) supple-
mented with 10% fetal bovine serum (FBS; Lonza, Basel,
Switzerland) and 1% penicillin/streptomycin (Gibco) in a hu-
midified atmosphere of 95% air and 5% CO2 at 37C. Lenti-
viral overexpression of HIF-1a was performed as described
[25]. Briefly, cells were transduced with pWPI-green fluores-
cent protein (GFP) or pWPI-HIF-1a-GFP expression vectors
(http://addgene.org cat. #12254) daily for 3 days. Transduction
efficiency was evaluated by flow cytometry and the percentage
of infection was routinely higher than 90%. Cells were ex-
panded and cryopreserved until use.
Transient transfection of HEK293T cells
HEK293T cells (6 · 106) were cultured in 10-cm2 dishes
with 10 mL of DMEM-high glucose supplemented with 10%
FBS and 1% penicillin/streptomycin. Twenty-four hours
after seeding and 1 h before transfection, the medium was
replenished and supplemented with 25 mM chloroquine
(Sigma-Aldrich, Madrid, Spain). Cells were transduced with
a mixture of 20 mg of EF.hICN1.Ubc.GFP, 62 mL of 2 M
CaCl2, and 418 mL of H2O added gently dropwise to 500mL
2 · HBS (10 mM glucose, 40 mM HEPES, 10 mM KCl,
270 mM NaCl, 1.5 mM Na2HPO4, pH 7.1). After incubation
for 6–8 h, the medium was replenished without chloroquine,
and 2–3 days later, cells were analyzed by flow cytometry
and western blotting [anticleaved Notch1 (A-8,1:1,000);
Santa Cruz Biotechnology, Santa Cruz, CA) and real time
quantitative PCR (RT-qPCR) (Hes1, Hey1, and Hey2].
Induction of hypoxia in HEK293T cells
Cells were cultured under hypoxia (1% O2) in an Invivo2
400 workstation (Ruskinn Technology Ltd., Bridgend, United
Kingdom) for 4 h.
Activation/inhibition of Notch signaling pathway
To activate the Notch pathway, 60-cm2 culture plates
were coated with anti-human IgG-Fc (stock at 1.3 mg/mL,
7.4 mL/1.5 mL phosphate-buffered saline [PBS]; Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA) for
30 min at 37C, washed with PBS twice, and blocked with
DMEM plus 10% FBS for 1 h at 37C. Plates were washed
again twice with PBS and coated with Jag1-Fc for 2 h at
37C (stock at 200mg/mL, 8.1 mL from stock/1.5 mL PBS;
R&D Systems, Abingdon, United Kingdom). Then, control
or HIF-MSCs were seeded onto the coated plates for 24 h. In
some experiments, the gamma-secretase inhibitor RO4929097
(Xcess Biosciences, Inc., San Diego, CA) was used to inhibit
the Notch pathway (10mM for 48 h; 24 h before seeding cells
onto Jagged1-coated plates and repeated after seeding).
Inhibition of SUMOylation
To inhibit protein SUMOylation, cells were treated with
50 mM anacardic acid (AA; cat. #172050 Calbiochem,
Merck Millipore, Darmstadt, Germany) for 4 h. AA is a cell-
permeable ginkgolic acid analog that inhibits protein SUMO
modification by selectively targeting SUMO-activating en-
zyme E1 and interfering with E1-SUMO intermediate for-
mation. With the inhibition of this first step, subsequent
reactions of conjugation and ligation of SUMO to the target
proteins are abolished [26].
Migration assay
Cells were seeded in basal medium (DMEM plus 0.5%
FBS) at 10,000 cells/cm2 in the top chamber of an 8-mm-
pore Transwell chamber (BD Falcon, Bedford, MA). After
overnight culture, 25 ng/mL of IL-1b was added to the
bottom chamber for 8 h. DMEM plus 0.5% and 10% FBS
were used as negative and positive controls, respectively.
Nonmigrated cells were removed from the upper side of the
membrane with a cotton bud and migrated cells were fixed
with 70% cold ethanol for 10 min. The membrane was cut
and placed in a glass slide with the bottom side upward,
stained with DAPI, and migrated cells were counted.
Proliferation assay
Proliferation of MSCs was assessed by incorporation of
5¢-bromo-2¢-deoxyuridine (BrdU; Life Technologies, Ma-
drid, Spain). Cells were cultured at 50–60% confluence
on 11-mm diameter cover slides coated with Jagged 1 and
BrdU was added at 10mg/mL for 8 h. After this time, cells









































































were washed with PBS and fixed with 70% cold ethanol for
10 min at 4C. Slides were then washed three times with PBS
and 1 N HCl was added for 30 min at 37C. Subsequently, the
acid was neutralized with borate buffer for 10 min at room
temperature and, after five washes in PBS, slides were treated
with blocking buffer (PBS, 10% normal goat serum, 0.01%
Triton X-100) for 1 h at 37C, followed by addition of an anti-
BrdU antibody and incubation overnight at 4C (1:100 rat
anti-BrdU; Abcam, Cambridge, United Kingdom). After five
washes, an Alexa Fluor 555 (Invitrogen, Carlsbad, CA) sec-
ondary antibody was added for 2 h at room temperature and
positive nuclei were then counted.
Scratch-wound assay
To analyze spreading and invasiveness, cells were seeded
in 6-well culture plates and, once confluent, a scratch was
made on the monolayer with a p10 pipette tip. Debris was
removed with 1 mL of growth medium. Invasiveness of the
scratch was tracked using time-lapse microscopy and image
analysis was performed with ImageJ software (NIH).
Real time quantitative PCR
RNA was extracted using TRIzol reagent (Invitrogen) and
purified with the RNeasy Plus Mini Kit (Qiagen, Dusseldorf,
Germany). RNA was quantified spectrophotometrically
using a NanoDrop ND-1000 (NanoDrop Technologies, Wil-
mington, DE). cDNA was obtained by reverse transcription
using M-MLV reverse transcriptase (Invitrogen). RT-qPCR
was performed with the following human-specific sense and
antisense primers: Hes1 5¢-AAGAAAGATAGCTCGCGGCA-3¢
(forward) and 5¢-TACTTCCCCAGCACACTTGG-3¢ (reverse);
Hey1 5¢-AGGTAATGGAGCAAGGATCTGC-3¢ (forward) and
5¢-CCCGAAATCCCAAACTCCGA-3¢ (reverse); Hey2 5¢-GGA
TTATAGAGAAAAGGCGTC-3¢ (forward) and 5¢-GTTTTTCA
AAAGCAGTTGGC-3¢ (reverse); and ACTB 5¢-AGAGCCTC
GCCTTTGCCGATCC-3¢ (forward) and 5¢-CATGCCGGAGC
CGTTGTCGAC-3¢ (reverse) and SYBR Green I 1 · Light-
Cycler 480 SYBR Green I Master Mix (Roche Molecular
Biochemical, Mannheim, Germany). Multiwell plates of 96
wells were run on a LightCycler 480 Instrument (Roche Di-
agnostics, Mannheim, Germany).
Subcellular fractionation
Cells were seeded onto Jagged1-coated plates to activate
Notch signaling for 24 h in DMEM-low glucose supple-
mented with 10% FBS and 1% penicillin/streptomycin.
Cells were treated (+) or not (2) with AA (4 h, mM). Then,
cells were washed twice with cold PBS, lysed in 500 mL of
subcellular fractionation buffer (250 mM sucrose, 20 mM
HEPES pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA,
1 mM EGTA, 1 mM DTT, and protease/phosphatase inhib-
itor cocktail), and shaken on a tube roller at 30–50 rpm for
30 min at 4C. The lysate was centrifugated at 720 g for
10 min at 4C and the pellet was washed twice with the above
buffer and centrifuged as before. The supernatant was col-
lected and centrifugated at 10,000 g for 10 min at 4C. The
pellet from the previous step was lysed in nuclear lysis buffer
(50 mM Tris-HCl pH8, 150 mM NaCl, 1% NP-40, 0.5% so-
dium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 10%
glycerol, and protease/phosphatase inhibitor cocktail) and
shaken on a tube roller at 30–50 rpm for 15 min, 4C, to obtain
the nuclear fraction. Once centrifugated, the supernatant was
collected and centrifugated at 100,000 g for 1 h at 4C. The
supernatant from this step corresponded to the cytosolic
fraction. Cytosolic and nuclear fractions were quantified by
the Pierce BCA Protein Assay Kit (Thermo Fisher Scien-
tific, Rockford, IL). Equal amounts of protein were resolved
by 10% sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE), transferred to PVDF membranes
(Thermo Scientific), and blocked with 5% dry milk in Tris-
buffered saline. Membranes were incubated overnight at 4C
with the following primary antibodies at 1:1,000 dilution: anti-
Notch1 intracellular domain (N1ICD), anti-GAPDH as a load-
ing control for cytosolic fraction, and anti-histone 3 (H3) as a
nuclear fraction loading control (all from Cell Signaling
Technology, Europe, Schuttersveld, Leiden, The Netherlands).
The membranes were then exposed to HRP-conjugated sec-
ondary antibodies (1:10,000; Promega, Madison, WI) for 1 h at
room temperature. Immunoreactivity was detected with Su-
perSignal WestFemto (Thermo Fisher Scientific, Waltham,
MA) and densitometry was performed with ImageJ.
Immunoprecipitation assay
Cells were seeded onto Jagged1-coated plates to activate
Notch signaling for 24 h in DMEM-low glucose supple-
mented with 10% FBS and 1% penicillin/streptomycin.
Cells were lysed with 1 mL of ionic buffer (50 mM Tris-HCl
pH 8, 150 mM NaCl, 0.5% NP40, 0.5% sodium deoxy-
cholate, and 0.05% SDS) supplemented with protease in-
hibitor cocktail, phosphatase inhibitor, and 10 mM MG132
(all from Roche). Protein A/G Plus-agarose (Santa Cruz
Biotechnology, Santa Cruz, CA) and cleaved Notch1 (Val
1744; Cell Signaling Technology) were used for immuno-
precipitation. Agarose beads were washed several times
with cold Tris buffer containing 1 mM Tris, pH 7.4, and
15 mM NaCl (TBS) and blocked with 3% bovine serum
albumin in TBS. Whole lysates were precleared with aga-
rose beads and then incubated overnight (rocking at 4C)
with cleaved Notch1 antibody. Whole cell lysates were
added onto new pellets of agarose beads (previously blocked
with bovine serum albumin) and incubated for 3 h in a
rocking wheel at 4C. Finally, the supernatant was removed
and beads were washed several times with cold 1 · TBS-T
(TBS supplemented with 0.05% Tween). Proteins were
eluted with 2 · Laemmli buffer supplemented with dithio-
threitol and denatured for 5 min at 99C.
Electrophoresis and western blotting
Cells were washed with PBS and lysed in RIPA buffer
(1.5 M NaCl, 10% Nonidet P-40, 500 mM Tris-HCl, 5%
deoxycholate, and 1% SDS, pH 8) supplemented with pro-
tease inhibitors, PMSF and leupeptin (Roche). Lysis was
completed by five freeze–thaw cycles, followed by centri-
fugation at 12,000 g for 10 min 4C. Protein concentration
determination and electrophoresis were as described above.
Membranes were incubated overnight at 4C with the fol-
lowing primary antibodies (1:1,000 dilution): anti-Jagged1,
anti-Jagged2, anti-Dll1, anti-Dll3, and anti-Dll4 (all from
Cell Signaling Technology Europe, Schuttersveld, Leiden,
The Netherlands), anticleaved Notch1 (A-8; Santa Cruz),









































































and anti-HIF-1a (ab1; Abcam). An antibody to tubulin
(T5158; Sigma) was used as a loading control. Exposure to
secondary antibodies and immunoreactivity were performed
as described above.
Immunocytochemistry and confocal microscopy
Cells in DMEM-low glucose medium were seeded onto
11-mm diameter slides. After 2 days, the slides were washed
twice with PBS and cells were fixed with cold 70% ethanol
for 10 min at 4C. After three washes with PBS, the slides
were incubated for 1 h at 37C with blocking buffer consisting
of PBS with 10% newborn goat serum (Gibco) and 0.01%
Triton X-100 (Pronadisa, Basel, Switzerland). Cells were
overlaid with the primary antibodies anti-HIF-1-a (H1alpha67,
1:200; Abcam) or antiactivated Notch1 (1:200; Abcam) diluted
in blocking buffer and PBS (1:1) and incubated overnight at
4C. The slides were then rinsed five times with PBS and
overlaid with the secondary antibodies, Alexa Fluor 555 goat
anti-rabbit and Alexa Fluor 647 goat anti-mouse (both 1:1,000;
Invitrogen). Immunocytochemistry of negative controls was
performed to discriminate between autofluorescence and spe-
cific signals. Slides were analyzed by vertical microscopy
with a · 63 immersion objective (Leica 0.3). Quantification of
fluorescence was performed using ImageJ.
InCell Analyzer quantification
N1ICD nuclear translocation was measured by immuno-
labeling. Cells were cultured in 24-well plates in triplicate in
DMEM with 10% FBS and 1% penicillin/streptomycin and
then fixed with 70% cold ethanol for 10 min at 4C. Cells
were labeled with antiactivated Notch1 antibody (ab8925;
Abcam). The secondary antibody used was Alexa Fluor-555
(Invitrogen) and DAPI was used for nuclear labeling. Images
were acquired with an InCell Analyzer 1000 epifluorescence
microscope (GE Healthcare, Cardiff, United Kingdom). A
20 · objective was used to collect the fluorescence signals, and
a combination of two excitation (EX) and emission (EM)
filters was applied to detect DAPI (EX 405 nm/EM 450 nm)
and red fluorescence from antiactivated Notch1 (EX 530 nm/
EM 620 nm). Fifteen fields were acquired for each well.
Analysis was performed with the InCell Analyzer 1000
Workstation software. Cells were first defined using the
nuclear segmentation based on DAPI. The red signal was
used to define N1ICD localization in the cell.
Statistical analysis
Data are expressed as mean – standard error of mean or
standard deviation as indicated. Comparisons were per-
formed using unpaired Student’s t-test. Statistical values
were calculated using GraphPad Prism 6 software. Differ-
ences were considered statistically significant at P < 0.05
with a 95% confidence interval.
Results
HIF-1a overexpression induces protein and gene
expression changes in MSCs
MSCs were transduced with pWPI-GFP (hereafter named
MSC) or with pWPI-HIF-1a-GFP (hereafter named HIF-
MSC) lentiviral vectors (Fig. 1A) as described [25] and
FIG. 1. HIF-1a overexpression in MSCs.
(A) pWPI GFP and HIF-GFP lentiviral
vectors. (B) Human dental pulp MSC lenti-
viral labeling with pWIPI-GFP (MSCs) and
pWIPI-HIF-GFP (HIF-MSCs) detected by
flow cytometric analysis of GFP. (C) HIF-
1a gene expression levels detected by RT-
qPCR in HIF-MSCs (gray) relative to MSCs
(black) and expressed as mean – SD of fold
change. (D) Levels of HIF-1a protein as
detected by western blotting with an anti-
HIF-1a antibody and quantification by den-
sitometry of exposed films in HIF-MSCs
(gray) relative to MSCs (black); a-tubulin
was used as a protein loading control. (E)
Confocal microscopy (representative im-
ages) of MSCs and HIF-MSCs showing
HIF-1a nuclear localization. Scale bar:
30 mm in upper and lower left panels and
5 mm in the remaining panels. Data represent
mean – SD of three independent experi-
ments. *P < 0.05, ***P < 0.001. GFP, green
fluorescent protein; HIF1a, hypoxia-inducible
factor 1 alpha; MSCs, mesenchymal stem
cells; RT-qPCR, real time quantitative PCR;
SD, standard deviation.









































































cultured in normoxia. After infection, >95% of cultured cells
were GFP positive (Fig. 1B). HIF-1a overexpression was
confirmed by qPCR analysis (Fig. 1C) and western blotting
(Fig. 1D), and confocal microscopy analysis showed nuclear
localization of HIF-1a in HIF-MSCs (Fig. 1E).
HIF-1a overexpression in MSCs increases
Notch signaling activation
Crosstalk between HIF and Notch signaling has been
recently described in some cancer cell lines [16,27], in
which Notch relays the hypoxia signal into increased met-
astatic potential. To address whether a similar system was
operating in MSCs, we assessed Notch signaling compo-
nents in MSC overexpressing HIF-1a and cultured on
Jagged1-coated plates at low confluence to prevent Notch
activation by cell–cell contact. The mRNA expression levels
of the Notch downstream targets, Hes1, Hey1, and Hey2,
were significantly increased by Jagged1 stimulation both in
MSCs (black bars) and in HIF-MSCs (gray bars), and this
increase was higher in HIF-MSCs than in MSCs (Fig. 2A),
suggesting a cooperative effect between HIF-1a and Notch
signaling. Notch signaling was abolished by treatment with
RO4929097, a selective gamma-secretase inhibitor that
impairs Notch receptor processing and generation of NICD
(Fig. 2A). To evaluate whether MSCs expressed Notch re-
ceptor ligands on the cell surface and whether these ligands
were functional, we performed western blotting on MSCs
and HIF-MSCs. Results showed that the Notch ligands
Jagged1, Dll1, Dll3, and Dll4, but not Jagged2, were all
expressed in MSCs and all were significantly increased in
cells expressing HIF (Fig. 2B). To test if the ligands were
functional and could activate Notch, we seeded HIF-MSCs
and MSCs at confluence onto plates in the absence of Jag-
ged1 and analyzed the expression of Notch downstream
genes. Under these conditions, the expression of Hes1 and
Hey2, but not Hey1, was significantly higher in HIF-MSCs
than in MSCs (Fig. 2C). These results indicate that Notch
signaling is activated in confluent HIF-MSCs and that more
than one Notch ligand could be implicated in the process.
Notch mediates migration and spreading
in HIF-MSCs
We have previously shown that HIF overexpression in
bone marrow-derived MSCs stimulates their migration and
invasion [25]. Given the well-documented role of Notch in
migration and invasion in homeostasis and cancer [20,28],
we investigated whether it participated in HIF-mediated
spreading of MSCs. Overexpression of HIF-1a in MSCs
significantly increased invasion, as measured by the scratch-
wound assay, and promoted the development of lamellipo-
dia and filopodia (Fig. 3A). The addition of RO4929097
to cultures blocked HIF-a-mediated invasion, which was
FIG. 2. HIF-1 enhances Notch signaling
in MSCs. (A) RT-qPCR analysis of Notch
downstream genes Hes1, Hey1, and Hey2 in
MSCs (black bars) and HIF-MSCs (gray
bars) cultured with (+) or without (-) re-
combinant Jagged1 (Jag) and RO4929097
(gamma-secretase inhibitor) as negative con-
trol. Data represent mean– SEM of three in-
dependent experiments. (B) Representative
western blots and quantification of Notch
ligands Jagged1, Jagged2, and Delta-like
family (Dll1, Dll3, and Dll4) in MSCs and
HIF-MSCs. Expression levels of Notch
ligands were quantified by densitometry of
exposed films (black bars for MSCs and
gray bars for HIF-MSCs). Data represent
mean – SEM of three independent experi-
ments. (C) RT-qPCR analysis of basal
expression of principal downstream genes
of Notch pathway signaling (Hes1, Hey1,
and Hey2) in confluent cells after 24-h
culture of MSCs (black bars) and HIF-
MSCs (gray bars). *P < 0.05; **P < 0.01.
SEM, standard error of mean.









































































similar to that of control MSCs (Fig. 3A). Likewise, the
HIF-mediated increase in migration of HIF-MSCs through a
gradient of IL-1b in the Transwell assay was abrogated by
treatment with RO4929097, pointing to the participation of
NICD in this process (Fig. 3B).
HIF-mediated cell proliferation is dependent
on SUMO, but not Notch
We next sought to evaluate the influence of Notch sig-
naling for MSC proliferation. HIF-MSC and MSC cultures
were seeded onto Jagged 1-coated plates to ensure Notch
pathway activation and were incubated with BrdU for 8 h in
the presence or absence of RO4929097. Subsequently, fixed
cells were immunostained with anti-BrdU antibodies. Con-
sistent with our previous results using bone marrow-derived
MSCs [25], HIF-1a overexpression increased MSC prolif-
eration as shown by a significant increase in BrdU incor-
poration; however, this effect was not abolished by
RO4929097, indicating that HIF-induced cell proliferation
is independent of Notch (Fig. 4A).
It has been reported that a fine balance between
SUMOylation/deSUMOylation is required for activation
of the hypoxia-signaling cascade, possibly through post-
translation modifications to HIF-1a [29]. To question the
potential role of SUMO in HIF-1a-mediated proliferation
in MSCs, we repeated the BrdU incorporation study using 50mM
AA, an inhibitor of SUMO ligase. As expected, cell proliferation
was significantly higher in HIF-MSCs than in MSCs; however,
the HIF-1a-mediated increase in cell proliferation was com-
pletely abolished by AA treatment, demonstrating the relevance
of the SUMO pathway for HIF-1a-induced MSC proliferation
(Fig. 4B).
HIF and Notch pathways are linked by SUMOylation
The above results suggested possible interplay between
HIF, Notch, and SUMO pathways. To investigate these po-
tential interactions, we first analyzed the influence of SUMO1
for the expression of Notch downstream genes. Treatment of
MSCs and HIF-MSCs with AA, under conditions of Notch
pathway activation, led to a decrease in the levels of expres-
sion of Hes1, Hey1, and Hey2 in both groups, but the decrease
was significant only for HIF-MSCs (Fig. 5A). Moreover,
global levels of SUMO were higher in HIF-MSCs than in
MSCs as measured by western blotting (Fig. 5B), suggest-
ing that HIF increases SUMO protein levels. Consistent
with previous studies, these results suggested an association
FIG. 3. Increased migration of
HIF-MSCs is dependent on Notch
pathway activation. (A) Repre-
sentative images of scratch-wound
assays showing MSC and HIF-
MSC migration at different time
intervals in the presence or absence
of RO4929097. Images were taken
at 100 · magnification. Dotted lines
define the wound area. Percentage
of invasion was calculated at the
indicated time intervals (black bars
for MSCs and gray bars for HIF-
MSCs). Scale bar: 100mm (B) Mi-
gration toward trophic factor IL-1b
in the presence or absence of
RO4929097. Cells were grown on
top of a Transwell membrane and
the bottom chamber contained IL-
1b at 25 ng/mL. After 8 h, cells that
migrated through the membrane
were stained with DAPI and coun-
ted (black bars for MSCs and gray
bars for HIF-MSCs). Images were
taken at 40 · magnification. Scale
bar: 100mm Data represent mean –
SEM of three independent experi-
ments. *P < 0.05; **P < 0.01.









































































between HIF and SUMO pathways. To explore this functional
relationship, we first analyzed the protein sequence of the
Notch1 receptor with SUMOplot Analysis software, a
program that predicts and scores SUMOylation sites in pro-
tein sequences. The results of this analysis showed six po-
tential motifs with high probability of representing the SUMO
binding site on the N1ICD (not shown). We next im-
munoprecipitated N1ICD in MSCs and HIF-MSCs with an
anti-N1ICD antibody and performed western blotting for
SUMO1. We observed that N1ICD was susceptible to
SUMOylation and, moreover, levels of SUMOylated N1ICD
were higher in HIF-MSCs than in MSCs (Fig. 5C). Additional
analysis using an InCell Analyzer to quantify N1ICD nuclear
translocation [30] confirmed that levels of N1ICD were sig-
nificantly higher in the nuclei of Notch-activated HIF-MSCs
than in equivalent MSCs and also showed that AA abolished
N1ICD nuclear translocation (Fig. 5D). Overall, these results
indicate a functional relationship between SUMO and
Notch1, whereby cellular SUMO levels can affect N1ICD
nuclear translocation. To further corroborate SUMOylation
of N1ICD, we performed subcellular fractionation experi-
ments and western blotting using MSCs and HIF-MSCs cul-
tured on Jagged 1-coated plates and treated or not with AA to
modulate SUMOylation. Analysis of N1ICD expression in
nuclear fractions revealed a reduction in nuclear expression of
the protein in the presence of the SUMO inhibitor (Fig. 5E).
SUMOylation mediates HIF-induced Notch
migration and invasiveness
To test the functional effect of SUMOylation for cell
invasion, we repeated the scratch-wound assays in HIF-
MSC and MSC cultures using AA to inhibit SUMOylation.
Results showed that AA treatment completely abolished the
increase in migration of HIF-MSC cultures (Fig. 6A, B).
These results establish a close relationship between the three
pathways.
SUMOylation of N1ICD is increased by hypoxia
in HEK293T cells
To validate the proposed model of N1ICD SUMOylation
in other cell lines, we transiently transfected HEK293T cells
with EF.hICN1.Ubc.GFP, a lentiviral vector encoding
N1ICD (N1ICD-293T). Flow cytometry analysis showed that
95% of cells were infected with the vector. Subsequently,
N1ICD expression was confirmed by western blotting using
N1ICD antibodies and quantified by densitometry (Fig. 7A).
In addition, genes downstream the Notch signaling pathway
(Hes1, Hey1, and Hey2) were analyzed by RT-qPCR (Fig. 7B)
and, as expected, were overexpressed in N1ICD-293T cells.
Cells were then cultured under hypoxic conditions (1% O2)
for 4 h in the presence or absence of AA (same conditions as
FIG. 4. Increased proliferation of HIF-
MSCs is Notch independent, but SUMO1
dependent. MSCs and HIF-MSCs were treated
or not with 10mM RO4929097 (RO) for 48 h
(A) or with 50 mM anacardic acid (AA) for 4 h
(B), and the proliferation rate was quantified
by BrdU incorporation (black bars for MSCs
and gray bars for HIF-MSCs). Images were
taken at 100 · magnification. Scale bar: 100 mm
Data represent mean – SEM of three in-
dependent experiments. *P < 0.05; **P < 0.01.
BrdU, 5¢-bromo-2¢-deoxyuridine; SUMO, small
ubiquitin-like modifier.









































































used for MSCs) and expression of HIF-1a and N1ICD was
evaluated by western blotting using anti-HIF-1a and anti-
activated Notch1 antibodies and quantified by densitometry.
As anticipated, hypoxia increased the steady-state levels of
HIF-1a (Fig. 7C). Next, Hes1, Hey1, and Hey2 genes were
analyzed by RT-qPCR and an increase in gene expression was
observed in N1ICD-293T cells exposed to hypoxia. More-
over, when hypoxic N1ICD-293T cells were treated with AA,
Hes1, Hey1, and Hey2 expression decreased significantly in
comparison with the levels in N1ICD-293T cells in normoxia
(treated or not with AA) (Fig. 7D). These results correlate
with previous findings observed in MSCs, suggesting that the
intracellular domain of the Notch1 receptor is SUMOylated,
which increases its nuclear translocation, and that this SU-
MOylation is enhanced by hypoxia or by HIF-1a. Finally, to
confirm SUMOylation of N1ICD, we performed immuno-
precipitation of N1ICD in N1ICD-293T cells under nor-
moxia/hypoxia and treated or not with AA. Protein extracts
were immunoprecipitated with an anti-N1ICD antibody and
SUMOylated proteins were detected using an anti-SUMO1
antibody. We observed that N1ICD was SUMOylated both in
normoxia and hypoxia and that treatment with AA decreased
this post-translational modification, especially under hypoxia
(Fig. 7E).
Discussion
MSCs can repair damaged tissues and we have previously
demonstrated that infusion of MSC overexpressing HIF-1a
promotes myocardial healing in an experimental rat model
of myocardial infarction. As described by us and others,
signaling pathways related to several paracrine factors and
interleukins are upregulated in HIF-MSCs. For example,
expression levels of p38 mitogen-activated protein kinase
FIG. 5. HIF-1a and SUMO1 increase nuclear
translocation of N1ICD. (A) RT-qPCR analysis
of Notch downstream genes Hes1, Hey1, and
Hey2 in MSCs and HIF-MSCs cultured in the
presence (+) or absence (2) of Jagged1 ( Jag)
and AA. Data represent mean – SEM of three
independent experiments. (B) Analysis of SU-
MOylation levels in MSCs and HIF-MSCs in
the presence (+) or absence (2) of AA. SU-
MOylation was detected with an anti-SUMO1
antibody. a-tubulin was used as a protein load-
ing control. (C) Immunoprecipitation of
N1ICD. MSC and HIF-MSC extracts from
cultures seeded on plates coated with Jagged1 to
ensure the pathway activation, treated (+) or not
(2) with AA, were immunoprecipitated with an
anti-N1ICD antibody, resolved by SDS-PAGE,
and immunoblotted with anti-SUMO1 anti-
body. (D) Representative immunofluorescence
images of N1ICD (red) in MSCs and HIF-MSCs
cultured in plates coated with Jagged1 (24 h)
with (+) or without (2) AA (4 h). N1ICD nu-
clear translocation is increased in HIF-MSCs,
which is reversed by AA. Scale bar: 50 mm.
Quantification was performed using an InCell
Analyzer for measurement of fluorescence units
in the nuclei. (E) Representative western blot of
MSC and HIF-MSC subcellular fractionation.
Cells were coated with Jagged1 to ensure the
pathway activation and cells were treated (+) or
not (2) with AA. Then, the amount of N1ICD in
nuclei under different conditions was quantified
by densitometry. GAPDH was used as a loading
control of cytosolic proteins and histone 3 (H3)
as a loading control of nuclear proteins. Data
represent mean – SEM of three independent
experiments. IB denotes immunoblot and IP
denotes immunoprecipitation. *P < 0.05; **P <
0.01, ***P < 0.001, {P < 0.05, {{{P < 0.001. { de-
notes significance of HIF-MSCs versus MSCs in
the presence of Jagged 1 (Jag+). Black bars for
MSCs and gray bars for HIF-MSCs in panels A, D,
and E. N1ICD, Notch1 intracellular domain; SDS-
PAGE, sodium dodecyl sulfate–polyacrylamide
gel electrophoresis.









































































(p38/MAPK) [25,31], JNK/SAP [25], AKT [25], and Notch
[32,33], together with fibronectin [34,35], fibroblast growth
factor [25,36], angiopoietin-1 (ANGPT1) [37], NGF [38],
and insulin growth factor [25,39] signaling pathways, are
all induced by HIF-1a. We examined Notch signaling
since hypoxia can promote Notch pathway activation
and HIF-1a is a key mediator in the adaptation of eu-
karyotic cells to hypoxia. We first compared Notch
downstream target gene expression in HIF-MSCs and
MSCs. Activation of Notch signaling in HIF-MSCs was
observed when HIF-MSCs were cultured at confluence
or seeded at low density on Jagged1-coated plates, in-
dicating that HIF-1a enhanced Notch signaling only
after activation of the Notch receptor. This is in accor-
dance with previous studies showing that hypoxia in-
creases activation levels of Notch1 in different tumor
cell lines only after coculture with a Jagged1-expressing
cell line [27].
We next analyzed the contribution of the Notch path-
way to HIF-MSC migration and proliferation since Notch
is a major participant in these processes [16,27,40]. We
found that migration and invasiveness, but not prolifera-
tion, were dependent on Notch signaling. The contribu-
tion of HIF-1a to enhanced Notch-dependent migration
and invasiveness has been previously described in cho-
riocarcinoma cell lines, suggesting that this is a general
mechanism in normal and tumor cells [16]. However, the
observation that increased cell proliferation in HIF-MSCs
was Notch independent pointed to the participation of
other mechanisms and led us to explore alternative
pathways. In this regard, a relationship has been described
between HIF-1a and the ubiquitin family member,
SUMO-1 [41,42]. In contrast to ubiquitination, SUMO-1
modifications enhance the stability of nuclear proteins
[43]. Previous studies have shown that HIF-1a undergoes
post-translational modification by the three isoforms of
SUMO (SUMO-1, -2, and -3) in vitro [44]. Increased
SUMO-1 mRNA and protein level have been reported
after hypoxic stimulation in various cell lines [45] and
in vivo [42]. Moreover, SUMOylation of HIF-1a results
in its stabilization and increases its transcriptional activity
[41]. To investigate whether SUMOylation was involved
in HIF/Notch crosstalk in MSCs, we cultured cells in the
presence or absence of AA, a SUMOylation inhibitor.
Under these conditions, we observed that both prolifera-
tion and migration were abolished and this effect was
stronger in HIF-MSCs. Western blotting showed an in-
crease in global SUMO levels in HIF-MSCs. Moreover,
immunoprecipitation studies showed higher amounts of
SUMOylated N1ICD in HIF-MSCs. Immunofluorescence
labeling, followed by InCell quantification, showed de-
creased nuclear translocation of NICD in HIF-MSCs in
the presence of AA, indicating that SUMOylation of
N1ICD favors the nuclear translocation of this transcrip-
tional factor and thus confirming that enhanced SUMO
pathway by HIF-1a overexpression might contribute to
FIG. 6. HIF-1a-enhanced cell mi-
gration is mediated by SUMO signal-
ing. (A) Representative images of a
time-lapse sequence of scratch-wound
assays at different time intervals in
MSCs and HIF-MSCs with cells trea-
ted (+) or not (-) with the SUMO in-
hibitor AA. Dotted lines define the
wound area. (B) Percentage of inva-
sion in MSCs (black bars) and HIF-
MSCs (gray bars) with cells treated
(+) or not (-) with AA calculated at
indicated time intervals. Images were
taken at 100 · magnification. Scale bar:
100 mm. Data represent mean – SEM
of four independent experiments.
**P < 0.01; ***P < 0.001.









































































the differential activation of the Notch pathway in MSC-
HIF with respect to MSCs.
Several mechanisms may explain the increased SUMOylation
of N1ICD in HIF-MSCs. First, it has been described that
HIF-1a can increase g-secretase activity, which would in-
crease N1ICD cleavage leading to higher cytosolic concen-
trations [46]. Second, the global increase in cytosolic SUMO
levels in HIF-MSCs could favor N1ICD SUMOylation.
Third, SUMOylated N1ICD could be more easily trans-
located to the nucleus since it is known that protein
SUMOylation promotes nuclear localization [30,47].
The effect of HIF-1a stabilization on MSCs is summa-
rized in the model proposed in Fig. 8. Overexpression of
HIF-1a leads to an increase in N1ICD levels by stabilization
of the transcription factor, increasing its half-life, or by
enhancing gamma-secretase enzyme activity [46,48,49].
Concurrently, HIF-1a increases the cellular amounts of
SUMO1, which is reflected by an increase in the SUMOylation
of N1ICD, a phenomenon described for the first time here.
This process together with N1ICD nuclear translocation is
important for cellular proliferation and migration, as well as
for tumoral processes where the independent roles of SUMO,
HIF, and Notch are well described. With this model, we are
able to explain how HIF-1a acts as a potent enhancer of
Notch transcriptional activity, enhancing the therapeutic
properties of hMSCs through SUMO1. Moreover, we es-
tablish a link between these two highly conserved pathways
and the key role of post-translational SUMO modification,
which is implicated in tissue renewal, regeneration, prolif-
eration, migration, invasiveness, and tumorigenesis.
FIG. 7. HIF-1a and SUMO1 increase nuclear translocation of N1ICD in HEK293T cells. (A) Representative
western blot and quantification of N1ICD by densitometry in transiently transfected HEK293T cells (black bars for
HEK293T and gray bars for N1ICD-293T cells). Data represent mean – SEM of three independent experiments.
(B) RT-qPCR analysis of Notch downstream genes Hes1, Hey1, and Hey2 in HEK293T (black bars) and N1ICD-
293T cells (gray bars). Data represent mean – SEM of three independent experiments. (C) Representative western
blot and quantification by densitometry of HIF-1a to assess hypoxia induction and N1ICD in HEK293T and
N1ICD-293T cells treated or not with AA. (D) RT-qPCR analysis of Notch downstream genes Hes1, Hey1, and
Hey2 in HEK293T and N1ICD-293T cultured in the presence (+) or absence (2) of hypoxia (Hx) and AA. Data
represent mean – SEM of three independent experiments. (E) Immunoprecipitation of N1ICD. HEK293T transduced
with an N1ICD lentiviral vector (N1ICD +) cultured under normoxic or hypoxic conditions (Hx +/-) and treated or
not with AA (+/-) were lysed and cell extracts were immunoprecipitated with an anti-N1ICD antibody, resolved
by SDS-PAGE, and immunoblotted with anti-SUMO1 antibody. Molecular weights of protein markers are indi-
cated at the left side of the panel in kDa. Data represent mean – SEM of three independent experiments. *P < 0.05;
**P < 0.01, ***P < 0.001.









































































In summary, we demonstrate at the molecular and cellular
levels the mechanism underlying HIF-SUMO-Notch cross-
talk in hMSCs and how this interaction results in (i) auto-
activation of Notch signaling pathway, (ii) increased Notch
ligand expression, (iii) increased levels of SUMO and SU-
MOylation of N1ICD, (iv) increased N1ICD nuclear trans-
location, and (v) increased migration, invasiveness, and
proliferation of HIF-MSCs. The relationship between the
Notch pathway and cancer is well recognized [50]. Thus,
this novel level of regulation for N1ICD could have po-
tential implications in cancer pathogenesis. Further studies
are needed to identify the residues SUMOylated in N1ICD
and to elucidate whether higher concentrations of N1ICD by
increased g-secretase activity or higher SUMO-mediated
nuclear translocation of N1ICD account for the enhanced
Notch activity in HIF-MSCs.
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